Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
about
Characterization and amino acid sequence of a fatty acid-binding protein from human heartPurification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogenLipid peroxidation during myocardial ischaemia induced by pacingPhospholipase A2: its usefulness in laboratory diagnostics.Incorporation of marine lipids into mitochondrial membranes increases susceptibility to damage by calcium and reactive oxygen species: evidence for enhanced activation of phospholipase A2 in mitochondria enriched with n-3 fatty acids.Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias.Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by palmitoyl carnitine.Cardiac ischemia. Part I--Metabolic and physiologic responsesEffects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytesThe rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia.Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes.Relationship between ionic perturbations and electrophysiologic changes in a canine Purkinje fiber model of ischemia and reperfusionImportance of adenosine triphosphate in phospholipase A2-induced rabbit renal proximal tubule cell injuryProphylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulationThe YhhN protein of Legionella pneumophila is a LysoplasmalogenaseCalcium in renal cells. Modulation of calcium-dependent activation of phospholipase A2Isolation of a human myocardial cytosolic phospholipase A2 isoform. Fast atom bombardment mass spectroscopic and reverse-phase high pressure liquid chromatography identification of choline and ethanolamine glycerophospholipid substrates.KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties.Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs.Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with the loss of contractile function and the development of calcium overloadThe effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends…Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine.Caprine cardiac sarcoplasmic reticulum: Effect of simulated ischemia on membrane structure and Ca(2+)-ATPase activity.Effects of L-propionylcarnitine on electrical and mechanical alterations induced by amphiphilic lipids in isolated guinea pig ventricular muscle.Cardiomyopathy associated with noninsulin-dependent diabetes.Delayed recovery of fatty acid metabolism after transient myocardial ischemia: a potential imaging target for "ischemic memory".Mitochondria and cardioprotection.Electrophysiologic mechanisms for ventricular arrhythmias in left ventricular dysfunction: electrolytes, catecholamines and drugs.Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection.Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction ratsPrimary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.Calcium and pH in anoxic and toxic injury.Alpha-adrenoceptors: a critical review.Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia.Cardiac excitability and antiarrhythmic drugs: a different perspective.Developmental cardiac metabolism in health and disease.Isolation of sarcolemmal membrane, membrane orientation, and lipid asymmetry.Future cardioprotective considerations.Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion.
P2860
Q24298506-ED12F3CC-8D5D-4B54-B80E-8B50C105330DQ24300234-0C835FAD-39C5-4AAB-B8A0-2E8F9A6333ADQ33610345-032EC8F1-975A-4A6A-97DD-A36C633FBF56Q33702391-78F7B0F6-92F3-46BC-ABC8-83BC66399F89Q33894334-9C8A1074-D5B1-44AC-A61E-FE09294454BBQ33993322-DAD35D6B-C93C-4CFF-8E43-39A700270D42Q34019555-62528145-17ED-49EA-819F-904BE80D556DQ34195605-38867BDD-371F-4764-BDD7-6379E80659C7Q34213115-3F410DFE-F9EE-4728-BDD4-A0772FAE1111Q34226079-244BB62C-8549-41D2-B33A-C8CC442939EEQ34401274-DEE618B5-A668-4814-B739-1CAA0B1E1ED4Q34557511-1D1418B7-FC07-41B7-8F03-05B147788363Q34563168-0E6BAB17-1FD2-4F68-9E1B-640F9A98ED27Q34568583-1D0872B7-D70B-4300-9568-A81456996EABQ34803733-6C7DD788-CF47-4F9C-89B4-978EBE37B05EQ35033037-091F73F5-0FA3-414E-B8D9-97A4394FA86FQ35610510-98F53FF9-EB6B-41DC-B60E-7905E5087061Q35673140-F7517ABA-8B9F-40C9-AC5A-F1BA0860698FQ35808499-EFE57690-96B9-4DA0-8300-B0B3EB44A487Q35836164-68E27770-E3AA-4ED2-AFF8-6EA2AD97E576Q35865078-98189646-F9D0-411D-850D-BF863733F755Q35873589-439507B2-4E44-4C12-B0B8-B291AAF8A2E3Q35887569-BA9E66DF-F647-4BE6-B4A3-99BC38A9C441Q36264738-CF4E3829-D82E-4F7F-8884-03FEE9FC0198Q36443257-DD1997C9-1117-4E72-AD31-2600CE3B1A2CQ36462620-E9191DB9-2FD0-41E2-9B29-FA791E1131A3Q36790152-09D6D63A-7EDC-4896-9B65-FE7879524420Q36827897-883259FF-19C6-47C2-A00B-52CF8E67B48EQ36832166-B2786CB8-C2D4-488A-99D4-6BE187D2B31EQ36862386-90BA7C85-3C65-4F04-9FDB-9FB5F0BF095EQ37125270-29E29B3E-0CD5-4391-A061-5567E91F3446Q37354300-ADA7AF1B-27EF-4DB2-8A69-CD003F47FE41Q37787068-F886DD9D-4578-4FDA-9F79-7CF667260C99Q38300649-9595CABB-E0DC-4454-BCBC-4ADB97B1857BQ38415182-EC6C555F-EDC8-4833-8FD2-B19124471843Q38651996-D7278044-2B68-464B-9D95-1B1FDF14286AQ38700986-7CDAF3DB-2D8D-4756-8937-CF7B934B14CDQ39670709-41F8A5BA-57C2-44D4-BD1E-C51E77231251Q40835768-92E6597D-1EC4-481A-A360-8A461218AAF6Q41017881-9265E179-4F9A-4D77-949D-B75EF420CA88
P2860
Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
@en
type
label
Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
@en
prefLabel
Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
@en
P2093
P356
P1433
P1476
Amphipathic metabolites and membrane dysfunction in ischemic myocardium.
@en
P2093
P304
P356
10.1161/01.RES.55.2.135
P577
1984-08-01T00:00:00Z